PRESS RELEASE published on 10/26/2023 at 06:45, 1 year ago Carbios obtains building and operating permits, in line with announced schedule, for world's first PET biorecycling plant in Longlaville
PRESS RELEASE published on 10/23/2023 at 18:00, 1 year ago Carbios Places Sustainability at the Heart of its Governance with New Appointment to its Executive Committee
PRESS RELEASE published on 10/12/2023 at 06:45, 1 year 1 month ago Carbios demonstrates superior performance of its enzyme in world-renowned scientific publication
PRESS RELEASE published on 10/02/2023 at 18:00, 1 year 1 month ago Carbios unveils major innovation in polyester recycling with new textile preparation line, in the presence of Roland Lescure, French Minister of Industry
PRESS RELEASE published on 09/28/2023 at 06:45, 1 year 1 month ago Carbios announces half-year 2023 financial results and corporate update
PRESS RELEASE published on 07/11/2023 at 18:30, 1 year 4 months ago Carbios announces the success of its capital increase with preferential subscription rights of approximately 141 million euros, the largest on Euronext Growth since 2015
PRESS RELEASE published on 06/28/2023 at 19:00, 1 year 4 months ago Carbios incorporates its Purpose into company statutes and presents the results of its Special Meeting and Annual General Meeting of 22 June 2023
PRESS RELEASE published on 06/22/2023 at 06:33, 1 year 4 months ago Carbios announces the launch of a rights issue totalling around €122 million, likely to be increased to around €141 million if the extension clause is fully exercised
PRESS RELEASE published on 06/06/2023 at 06:45, 1 year 5 months ago Carbios aims to be a leader in growing r-PET market with an ambition to capture 8 to 12% share by 2035 through licensing model
PRESS RELEASE published on 06/01/2023 at 18:30, 1 year 5 months ago Carbios and Indorama Ventures reaffirm partnership to build first-of-a-kind PET biorecycling plant in France
Published on 11/21/2024 at 13:30, 20 minutes ago AirIQ Announces September 30, 2024 Quarterly Results Company Reports Double-Digit Growth in Recurring Revenue
Published on 11/21/2024 at 13:30, 20 minutes ago Datametrex Secures Additional P.O. Approx $250K for IT Services
Published on 11/21/2024 at 13:00, 50 minutes ago Aclara Secures Funding from Corfo's Innovation High-Tech Program for Artificial Intelligence Project
Published on 11/21/2024 at 13:00, 50 minutes ago Telomir Pharmaceuticals Confirms Age Reversal, Increased Longevity and Improved Healthspan in Groundbreaking Preclinical Study with Telomir-1
Published on 11/21/2024 at 13:00, 50 minutes ago Toggle3D.ai Rebrands as FOTOgpt.ai to Usher in a New Age of AI-Powered Photography
Published on 11/21/2024 at 12:35, 1 hour 15 minutes ago audius with successful third quarter 2024 - total revenue grows by +9.2% and EBITDA by +14.6
Published on 11/21/2024 at 12:15, 1 hour 35 minutes ago Hardman & Co Investor Forum Research on Shield Therapeutics (STX): Proactive cash management to cashflow-breakeven
Published on 11/21/2024 at 06:58, 6 hours 52 minutes ago Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 18 hours 30 minutes ago Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 20 hours 5 minutes ago MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 20 hours 5 minutes ago Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
Published on 11/20/2024 at 07:45, 1 day 6 hours ago Gimv sells to Fremman Capital a majority stake in outpatient rehabilitation specialist rehaneo
